Doctors in Turkey manage CAR T-cell therapy through a synchronized pipeline involving cell collection, specialized transport, and inpatient monitoring. Leading hematologists integrate international logistics with Joint Commission International (JCI) accredited facilities. They use the vein-to-vein model to maintain cell viability during engineering and re-infusion processes.
- Cell collection: Specialists perform apheresis to harvest T-cells using temperature-controlled cryopreservation techniques.
- Manufacturing logistics: Teams coordinate with domestic labs or international hubs to engineer patient cells.
- Bridging therapy: Hematologists design temporary treatment regimens to stabilize the patient during the manufacturing period.
- Post-infusion care: Patients stay in isolated bone marrow units for 14+ days to monitor progress.
Bookimed Expert Insight: Turkish specialists provide a significant clinical advantage through their extensive training at top global institutions. Dr. Osman Ilhan at Private Koru Ankara Hospital trained at MD Anderson Cancer Center. Dr. Ceyhun Bozkurt of Medical Park studied at Harvard and Cincinnati Children's. This international background allows them to manage complex cross-border cell manufacturing protocols efficiently.
Patient Consensus: Patients describe the process as a multi-step puzzle that requires staying near the hospital for several weeks. They note it is helpful to have the medical team handle shipping and customs paperwork. Many emphasize that clear communication about lab timelines and bed availability helps reduce stress during the wait.